{
  "thread": {
    "uuid": "9ffda9a24e57a30346acfff784ef1601931407ae",
    "url": "https://www.manilatimes.net/2025/07/31/tmt-newswire/globenewswire/vedtechbio-unveils-next-gen-drug-discovery-ai-partners-with-alphameld-in-multi-therapy-collaboration/2159448",
    "site_full": "www.manilatimes.net",
    "site": "manilatimes.net",
    "site_section": "https://www.manilatimes.net/news",
    "site_categories": [
      "media",
      "top_news_ph",
      "top_news"
    ],
    "section_title": " News | The Manila Times ",
    "site_title": "The Manila Times | News | Opinion | Philippines | Asia | World",
    "title": "VedTechBio Unveils Next-Gen Drug Discovery AI; Partners with AlphaMeld in Multi-Therapy Collaboration | The Manila Times",
    "title_full": "VedTechBio Unveils Next-Gen Drug Discovery AI; Partners with AlphaMeld in Multi-Therapy Collaboration | The Manila Times",
    "published": "2025-07-31T07:04:00.000+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "PH",
    "main_image": "https://www.manilatimes.net/manilatimes/uploads/images/2025/07/31/695268.jpg",
    "performance_score": 0,
    "domain_rank": 6086,
    "domain_rank_updated": "2025-06-03T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "9ffda9a24e57a30346acfff784ef1601931407ae",
  "url": "https://www.manilatimes.net/2025/07/31/tmt-newswire/globenewswire/vedtechbio-unveils-next-gen-drug-discovery-ai-partners-with-alphameld-in-multi-therapy-collaboration/2159448",
  "ord_in_thread": 0,
  "author": "The Manila Times",
  "published": "2025-07-31T07:04:00.000+03:00",
  "title": "VedTechBio Unveils Next-Gen Drug Discovery AI; Partners with AlphaMeld in Multi-Therapy Collaboration | The Manila Times",
  "text": "BENGALURU, India, July 31, 2025 (GLOBE NEWSWIRE) -- VedTechBio Research Pvt. Ltd., a pioneer in AI-driven drug discovery, today announced major enhancements to its RxAgentAI™ platform cutting drug discovery timelines in half alongside a strategic collaboration with AlphaMeld Corporation to co-develop multiple therapies for metabolic and rare diseases.\nRxAgentAI is an autonomous, multi-agentic intelligence system augmented by deep, domain-specific knowledge. It redefines research workflows, orchestrating complex tasks from precise target identification to intricate drug design and testing.\nRxAgentAI’s unique expert-in-the-loop mode seamlessly integrates human expertise with agent outputs. This ensures unparalleled accuracy, transparency, and scientific rigour, resulting in impacts exemplified by:\n30% reduction in target and drug identification timelines50% compression of full target-disease-drug analysis workflowsRare disease landscape mapping shortened from 12 weeks to under 3 \"We’re building a future where AI proactively advances discovery,” said Sudhir Nagarajan, Founder and Managing Director, VedTechBio. \"RxAgentAI marks a fundamental shift from passive tools to collaborative intelligence, purpose-built for translational impact.”\nStrategic Alliance with AlphaMeld",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "positive",
  "categories": [
    "Science and Technology",
    "Economy, Business and Finance",
    "Health"
  ],
  "topics": [
    "Science and Technology->scientific research",
    "Science and Technology->medical research",
    "Science and Technology->biotechnology",
    "Economy, Business and Finance->healthcare industry",
    "Economy, Business and Finance->financial service",
    "Economy, Business and Finance->business strategy and marketing",
    "Health->drug rehabilitation",
    "Health->health treatment and procedure"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": null,
  "webz_reporter": false,
  "external_links": [],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [
      {
        "name": "Sudhir Nagarajan",
        "sentiment": "none"
      }
    ],
    "locations": [],
    "organizations": [
      {
        "name": "VedTechBio Research Pvt. Ltd.",
        "sentiment": "negative",
        "tickers": []
      },
      {
        "name": "AlphaMeld Corporation",
        "sentiment": "none",
        "tickers": []
      }
    ]
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": null,
    "top_news": [
      "top_news_ph",
      "top_news"
    ],
    "bias": "center",
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2025-07-31T08:06:04.647+03:00",
  "updated": "2025-08-01T09:08:52.000+03:00"
}